PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26118109-9	2015	BCRP inhibitor quercetin (50 mumol x L(-1)) significantly increased the accumulation of flecainide in MDCKII-BCRP cells (P < 0.05).	Quercetin	15-24	ATP binding cassette subfamily G member 2	Canis lupus familiaris	0-4	
26118109-9	2015	BCRP inhibitor quercetin (50 mumol x L(-1)) significantly increased the accumulation of flecainide in MDCKII-BCRP cells (P < 0.05).	Quercetin	15-24	ATP binding cassette subfamily G member 2	Canis lupus familiaris	109-113	
34959273-3	2021	The inhibition of BCRP was investigated for quercetin and its metabolites using BCRP/mBcrp1-overexpressing MDCKII cells by flow cytometry.	Quercetin	44-53	ATP binding cassette subfamily G member 2	Canis lupus familiaris	18-22	
21139040-0	2011	The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.	Quercetin	78-87	ATP binding cassette subfamily G member 2	Canis lupus familiaris	63-68	
21139040-2	2011	The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin.	Quercetin	125-134	ATP binding cassette subfamily G member 2	Canis lupus familiaris	45-77	
21139040-2	2011	The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin.	Quercetin	125-134	ATP binding cassette subfamily G member 2	Canis lupus familiaris	79-83	
21139040-2	2011	The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin.	Quercetin	125-134	ATP binding cassette subfamily G member 2	Canis lupus familiaris	85-90	
21139040-2	2011	The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin.	Quercetin	202-211	ATP binding cassette subfamily G member 2	Canis lupus familiaris	45-77	
21139040-2	2011	The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin.	Quercetin	202-211	ATP binding cassette subfamily G member 2	Canis lupus familiaris	79-83	
21139040-2	2011	The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin.	Quercetin	202-211	ATP binding cassette subfamily G member 2	Canis lupus familiaris	85-90	
21139040-3	2011	Our objective was to investigate whether kaempferol inhibits Bcrp-mediated quercetin efflux and determine whether it is a substrate for BCRP.	Quercetin	75-84	ATP binding cassette subfamily G member 2	Canis lupus familiaris	61-65	
21139040-11	2011	We report for the first time that kaempferol is a Bcrp substrate, and our results indicate that kaempferol inhibits Bcrp-mediated quercetin efflux.	Quercetin	130-139	ATP binding cassette subfamily G member 2	Canis lupus familiaris	116-120